<p>根据 AlphaCore Capital LLC 最近向证券交易委员会提交的 13F 表格，该公司在第一季度将其在丹纳赫公司（NYSE:DHR - 免费报告）的持股增加了 168.9%。该公司在此期间额外购买了 6,134 股后，持有该综合企业的 9,766 股股票。截至其最近的 SEC 文件，AlphaCore Capital LLC 在丹纳赫的持股价值为 2,002,000 美元。</p>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>其他一些对冲基金最近也调整了对该公司的持股。Fayez Sarofim &amp; Co 在第一季度将其在丹纳赫的持股增加了 2.0%。Fayez Sarofim &amp; Co 现在拥有 8,454 股该综合企业的股票，价值 1,733,000 美元，此前在上个季度额外购买了 167 股。三菱 UFJ 资产管理有限公司在第一季度将其在丹纳赫的持股增加了 11.9%。三菱 UFJ 资产管理有限公司现在拥有 1,145,711 股该综合企业的股票，价值 234,871,000 美元，此前在上个季度额外购买了 122,015 股。Evernest Financial Advisors LLC 在第一季度将其在丹纳赫的持股增加了 4.6%。Evernest Financial Advisors LLC 现在拥有 4,962 股该综合企业的股票，价值 1,017,000 美元，此前在此期间额外购买了 216 股。Headlands Technologies LLC 在第一季度将其在丹纳赫的持股增加了 30.6%。Headlands Technologies LLC 现在拥有 54,640 股该综合企业的股票，价值 11,201,000 美元，此前在此期间额外购买了 12,816 股。最后，1834 Investment Advisors Co.在第一季度将其在丹纳赫的持股增加了 3.3%。1834 Investment Advisors Co.现在拥有 1,666 股该综合企业的股票，价值 342,000 美元，此前在上个季度额外购买了 54 股。机构投资者持有该公司 79.05% 的股票。</p>
<h2>丹纳赫的内部交易</h2>
<p>在丹纳赫的其他新闻中，董事长 Steven M. Rales 于 5 月 12 日星期一出售了 1,250,000 股该公司的股票。该股票以平均价格 196.74 美元出售，总交易额为 245,925,000.00 美元。交易完成后，董事长在公司中持有 3,105,808 股，价值 611,036,665.92 美元。此次交易使其持股减少了 28.70%。该出售在向证券交易委员会的文件中披露，相关信息可在此链接查看。当前 11.10% 的股票由内部人士持有。</p>
<h2>丹纳赫的价格表现</h2>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>丹纳赫的股票在周五开盘价为 198.48 美元。该公司的速动比率为 1.22，流动比率为 1.62，债务与股本比率为 0.32。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 279.90 美元。该公司的 50 日移动平均线为 198.24 美元，200 日移动平均线为 201.53 美元。该公司的市值为 1,421.2 亿美元，市盈率为 42.23，PEG 比率为 2.72，贝塔值为 0.73。</p>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 7 月 22 日（星期二）发布了季度财报。该综合企业报告每股收益（EPS）为 1.80 美元，超出分析师一致预期的 1.64 美元，超出幅度为 0.16 美元。丹纳赫的股本回报率为 10.70%，净利润率为 14.21%。该公司在本季度的收入为 59.4 亿美元，而一致预期为 58.3 亿美元。去年同期，该公司每股收益为 1.72 美元。丹纳赫的收入同比增长了 3.4%。卖方分析师预测丹纳赫公司在本财年将发布 7.63 美元的每股收益。</p>
<h2>分析师的升级和降级</h2>
<ul>
<li>丹纳赫的股票在 2024 年会创下新高吗？</li>
</ul>
<p>一些分析师最近对 DHR 股票发布了报告。摩根大通将丹纳赫的目标价从 280.00 美元下调至 260.00 美元，并在 4 月 22 日的研究报告中对该公司给予 “增持” 评级。杰富瑞金融集团将丹纳赫的目标价从 260.00 美元下调至 230.00 美元，并在 4 月 22 日的研究报告中对该公司给予 “买入” 评级。加拿大皇家银行重申了 “跑赢大盘” 的评级，并在 4 月 23 日的研究报告中对丹纳赫的股票发布了 250.00 美元的目标价。德意志银行将丹纳赫的目标价从 240.00 美元下调至 235.00 美元，并在 6 月 5 日的研究报告中发布。最后，Evercore ISI 将丹纳赫的目标价从 230.00 美元下调至 226.00 美元，并在 7 月 8 日的研究报告中对该股票给予 “跑赢大盘” 的评级。三位投资分析师对该股票给予持有评级，十八位分析师对该公司给予买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 247.61 美元。</p>
<p><strong>查看我们最新的丹纳赫股票分析</strong></p>
<h2>丹纳赫公司简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和制造；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液、色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如全制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票超过丹纳赫</li>
<li>高股息房地产投资信托：它们是理想的多元化方式吗？</li>
<li>为什么单片电源的收益和指引引发了市场反弹</li>
<li>如何一步一步购买便宜股票</li>
<li>AppLovin 第二季度业绩不佳让市场紧张，但华尔街加倍押注</li>
<li>如何开始投资便士股票</li>
<li>微软股票上涨，分析师提高了目标价</li>
</ul>
<p><strong>想看看其他对丹纳赫感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>AlphaCore Capital LLC 在第一季度将其在丹纳赫公司（NYSE:DHR）的持股增加了 168.9%，额外购买了 6,134 股，总持股达到 9,766 股，价值 2,002,000 美元。其他对冲基金也调整了他们的持股，Fayez Sarofim & Co 和三菱 UFJ 资产管理公司增加了他们的仓位。丹纳赫报告第二季度每股收益为 1.80 美元，超出预期，收入为 59.4 亿美元。分析师对丹纳赫的目标价格各不相同，摩根大通将其目标从 280 美元下调至 260 美元，而其他分析师则维持买入或跑赢大盘的评级</p>

<p>AlphaCore Capital LLC grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 168.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,766 shares of the conglomerate's stock after acquiring an additional 6,134 shares during the period. AlphaCore Capital LLC's holdings in Danaher were worth $2,002,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根据 AlphaCore Capital LLC 最近向证券交易委员会提交的 13F 表格，该公司在第一季度将其在丹纳赫公司（NYSE:DHR - 免费报告）的持股增加了 168.9%。该公司在此期间额外购买了 6,134 股后，持有该综合企业的 9,766 股股票。截至其最近的 SEC 文件，AlphaCore Capital LLC 在丹纳赫的持股价值为 2,002,000 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>A number of other hedge funds have also recently modified their holdings of the business. Fayez Sarofim &amp; Co increased its position in Danaher by 2.0% in the first quarter. Fayez Sarofim &amp; Co now owns 8,454 shares of the conglomerate's stock worth $1,733,000 after buying an additional 167 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Danaher by 11.9% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,145,711 shares of the conglomerate's stock worth $234,871,000 after acquiring an additional 122,015 shares in the last quarter. Evernest Financial Advisors LLC raised its stake in Danaher by 4.6% during the 1st quarter. Evernest Financial Advisors LLC now owns 4,962 shares of the conglomerate's stock worth $1,017,000 after acquiring an additional 216 shares during the period. Headlands Technologies LLC raised its stake in Danaher by 30.6% during the 1st quarter. Headlands Technologies LLC now owns 54,640 shares of the conglomerate's stock worth $11,201,000 after acquiring an additional 12,816 shares during the period. Finally, 1834 Investment Advisors Co. lifted its holdings in Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock valued at $342,000 after purchasing an additional 54 shares in the last quarter. Institutional investors own 79.05% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也调整了对该公司的持股。Fayez Sarofim &amp; Co 在第一季度将其在丹纳赫的持股增加了 2.0%。Fayez Sarofim &amp; Co 现在拥有 8,454 股该综合企业的股票，价值 1,733,000 美元，此前在上个季度额外购买了 167 股。三菱 UFJ 资产管理有限公司在第一季度将其在丹纳赫的持股增加了 11.9%。三菱 UFJ 资产管理有限公司现在拥有 1,145,711 股该综合企业的股票，价值 234,871,000 美元，此前在上个季度额外购买了 122,015 股。Evernest Financial Advisors LLC 在第一季度将其在丹纳赫的持股增加了 4.6%。Evernest Financial Advisors LLC 现在拥有 4,962 股该综合企业的股票，价值 1,017,000 美元，此前在此期间额外购买了 216 股。Headlands Technologies LLC 在第一季度将其在丹纳赫的持股增加了 30.6%。Headlands Technologies LLC 现在拥有 54,640 股该综合企业的股票，价值 11,201,000 美元，此前在此期间额外购买了 12,816 股。最后，1834 Investment Advisors Co.在第一季度将其在丹纳赫的持股增加了 3.3%。1834 Investment Advisors Co.现在拥有 1,666 股该综合企业的股票，价值 342,000 美元，此前在上个季度额外购买了 54 股。机构投资者持有该公司 79.05% 的股票。</p>
</div><h2>Insider Transactions at Danaher</h2>
<div class="lb-trans"><h2>丹纳赫的内部交易</h2>
</div><p>In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在丹纳赫的其他新闻中，董事长 Steven M. Rales 于 5 月 12 日星期一出售了 1,250,000 股该公司的股票。该股票以平均价格 196.74 美元出售，总交易额为 245,925,000.00 美元。交易完成后，董事长在公司中持有 3,105,808 股，价值 611,036,665.92 美元。此次交易使其持股减少了 28.70%。该出售在向证券交易委员会的文件中披露，相关信息可在此链接查看。当前 11.10% 的股票由内部人士持有。</p>
</div><h2>Danaher Price Performance</h2>
<div class="lb-trans"><h2>丹纳赫的价格表现</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>Danaher stock opened at $198.48 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The firm's fifty day moving average is $198.24 and its 200 day moving average is $201.53. The company has a market cap of $142.12 billion, a price-to-earnings ratio of 42.23, a PEG ratio of 2.72 and a beta of 0.73.</p>
<div class="lb-trans"><p>丹纳赫的股票在周五开盘价为 198.48 美元。该公司的速动比率为 1.22，流动比率为 1.62，债务与股本比率为 0.32。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 279.90 美元。该公司的 50 日移动平均线为 198.24 美元，200 日移动平均线为 201.53 美元。该公司的市值为 1,421.2 亿美元，市盈率为 42.23，PEG 比率为 2.72，贝塔值为 0.73。</p>
</div><p>Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the company earned $1.72 earnings per share. Danaher's revenue was up 3.4% on a year-over-year basis. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 7 月 22 日（星期二）发布了季度财报。该综合企业报告每股收益（EPS）为 1.80 美元，超出分析师一致预期的 1.64 美元，超出幅度为 0.16 美元。丹纳赫的股本回报率为 10.70%，净利润率为 14.21%。该公司在本季度的收入为 59.4 亿美元，而一致预期为 58.3 亿美元。去年同期，该公司每股收益为 1.72 美元。丹纳赫的收入同比增长了 3.4%。卖方分析师预测丹纳赫公司在本财年将发布 7.63 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><ul>
<li>Will Danaher stock hit new highs in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>丹纳赫的股票在 2024 年会创下新高吗？</li>
</ul>
</div><p>A number of analysts have recently issued reports on DHR shares. JPMorgan Chase &amp; Co. reduced their price objective on shares of Danaher from $280.00 to $260.00 and set an &#34;overweight&#34; rating for the company in a research note on Tuesday, April 22nd. Jefferies Financial Group cut their price target on Danaher from $260.00 to $230.00 and set a &#34;buy&#34; rating for the company in a research note on Tuesday, April 22nd. Royal Bank Of Canada restated an &#34;outperform&#34; rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft cut their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Evercore ISI decreased their target price on Danaher from $230.00 to $226.00 and set an &#34;outperform&#34; rating on the stock in a research note on Tuesday, July 8th. Three investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $247.61.</p>
<div class="lb-trans"><p>一些分析师最近对 DHR 股票发布了报告。摩根大通将丹纳赫的目标价从 280.00 美元下调至 260.00 美元，并在 4 月 22 日的研究报告中对该公司给予 “增持” 评级。杰富瑞金融集团将丹纳赫的目标价从 260.00 美元下调至 230.00 美元，并在 4 月 22 日的研究报告中对该公司给予 “买入” 评级。加拿大皇家银行重申了 “跑赢大盘” 的评级，并在 4 月 23 日的研究报告中对丹纳赫的股票发布了 250.00 美元的目标价。德意志银行将丹纳赫的目标价从 240.00 美元下调至 235.00 美元，并在 6 月 5 日的研究报告中发布。最后，Evercore ISI 将丹纳赫的目标价从 230.00 美元下调至 226.00 美元，并在 7 月 8 日的研究报告中对该股票给予 “跑赢大盘” 的评级。三位投资分析师对该股票给予持有评级，十八位分析师对该公司给予买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 247.61 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Danaher</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的丹纳赫股票分析</strong></p>
</div><h2>Danaher Profile</h2>
<div class="lb-trans"><h2>丹纳赫公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和制造；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液、色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，例如全制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>High Dividend REITs: Are They an Ideal Way to Diversify?</li>
<li>Why Monolithic Power's Earnings and Guidance Ignited a Rally</li>
<li>How to Buy Cheap Stocks Step by Step</li>
<li>AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down</li>
<li>How to start investing in penny stocks</li>
<li>Microsoft Stock Gains as Analysts Boost Price Targets</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过丹纳赫</li>
<li>高股息房地产投资信托：它们是理想的多元化方式吗？</li>
<li>为什么单片电源的收益和指引引发了市场反弹</li>
<li>如何一步一步购买便宜股票</li>
<li>AppLovin 第二季度业绩不佳让市场紧张，但华尔街加倍押注</li>
<li>如何开始投资便士股票</li>
<li>微软股票上涨，分析师提高了目标价</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding DHR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对丹纳赫感兴趣的对冲基金持有哪些股票吗？</strong> 请访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

AlphaCore Capital LLC 收购了丹纳赫公司（NYSE:DHR）6,134 股股票